Latest Edwards Lifesciences News & Updates

See the latest news and media coverage for Edwards. We track all announcements, press releases, and industry mentions in real time, all in one place.

Edwards Lifesciences (Edwards)

Structural heart medical device manufacturer

edwards.com

Headquarters: Irvine, United States
Founded year: 1958
Company type: Public company
Number of employees: 14,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated October 21

Latest news about Edwards Lifesciences (Edwards)

In short: Edwards won FDA approvals, delivered strong quarterly results, raised guidance, and faced regulatory penalties.

Company announcements

September 10 Edwards

Edwards Lifesciences welcomes CMS TAVR coverage update

The company reaffirms its 2026 financial guidance and highlights improved patient access for transcatheter aortic valve replacement procedures.

September 4 Edwards

Edwards Lifesciences reports strong Q2 earnings and raises annual guidance

Second quarter sales grew 13.6% to $1.74 billion, driven by TAVR and structural heart therapies. The company increases its full-year constant currency sales growth forecast to 10-11%. Updated financial projections confirm adjusted EPS guidance of $2.95 to $3.05.

August 15 Edwards

Edwards reports Q2 2026 results with net income of $622.6 million

The company recorded $1.7 billion in sales and recognized significant impairment losses totaling $163.6 million.

July 23 Edwards

Edwards reports Q2 2026 sales growth of 13.6%

Sales rose to $1.74B, driven by TAVR and TMTT; adjusted EPS of $0.78 beat expectations.

Media coverage

October 21 MassDevice

Edwards wins FDA approval for Pascal Precision in tricuspid valve repair

The FDA's approval in tricuspid regurgitation adds the clip-based Pascal Precision alongside Edwards' Evoque implant for replacing the valve.

October 21 Medical Device Online

With Pascal Precision Approval, Edwards Completes Full Mitral-to-Tricuspid Device Portfolio

Edwards said FDA approval of Pascal Ace with capture clarity simplifies mitral TEER procedures for clinicians. Edwards Lifesciences reported that FDA has approved its Pascal...

October 15 Reuters

FDA flags Edwards heart-valve delivery system issue after death, injury

The US FDA on Thursday warned of a potentially high-risk issue involving ‌certain Edwards Lifescien...

October 12 Medical Economics

Edwards Lifesciences reports strong Q4 growth, raises confidence in 2026 outlook | Medical Economics

Edwards Lifesciences reported double-digit fourth-quarter sales growth and said expanding demand for its · structural heart therapies is strengthening the company’s confidence in continued growth...

Never miss news about Edwards

Track Edwards and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Edwards competitors & trending companies

Browse news for competitors to Edwards and other trending companies.